NDC11 76420000705
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 76420-0007-05 | 76420-0007 |
| 76420-0007-5 | 76420-0007 |
| 76420-007-05 | 76420-007 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betamethasone Sodium Phosphate and Betamethasone Acetate | BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE | Asclemed USA, Inc. | c0a09d83-2405-450b-9f35-803d12823213 | 2022-10-12 | Warnings, Adverse reactions | 76420-007-05 76420-007 76420000705 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.